Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2001

[Federal Register: February 14, 2001 (Volume 66, Number 31)] [Notices] [Page 10320-10321] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr14fe01-87]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 23, 2000, and December 5, 2000, Cerilliant Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
Cathinone (1235)  I 
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N,N-Dimethylamphetamine (1480) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) (1590) I
Gamma hydroxybutyric acid (2010) I
Methaqualone (2565) I
Alpha-Ethyltryptamine (7249) I
Lysergic acid diethylamide (7315) I
Tetrahydrocannabinols (7370) I
Mescaline (7381) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetaime (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,4-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
Bufotenine (7433) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
Psilocybin (7437) I
Psilocyn (7438) I
Acetyldihydrocodeine (9051) I
Benzylmorphine (9052) I
Codeine-N-oxide (9053) I
Dihydromorphine (9145) I
Heroin (9200) I
Morphine-N-oxide (9307) I
Normorphine (9313) I
Pholcodine (9314) I
Acetylmethadol (9601) I
Allyprodine (9602) I
Alphacetylmethadol except Levo-Alphacetylmethadol (9603) I
Alphameprodine (9604) I
Alphamethadol (9605) I
Betacetylmethadol (9607) I
Betameprodine (9608) I
Betamethadol (9609) I
Betaprodine (9611) I
Hydromorphinol (9627) I
Noracymethadol (9633) I
Norlevorphanol (9634) I
Normethadone (9635) I
Trimeperidine (9646) I
Para-Fluorofentanyl (9812) I
3-Methylfentanyl (9813) I
Alpha-methylfentanyl (9814) I
Acetyl-alpha-methylfentanyl (9815) I
Beta-hydroxyfentanyl (9830) I
Beta-hydroxy-3-methylfentanyl (9831) I

[[Page 10321]]

Drug Schedule
Alpha-Methylthiofentanyl (9832) I
3-Methylthiofentanyl (9833) I
Thiofentanyl (9835) I
Amphetamine (1100) II
Methamphetamine (1105) II
Phenmetrazine (1631)  II
Methylphenidate (1724)  II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315)  II
Glutethimide (2550)  II
Nabilone (7379) II
1-Phenylcyclohexylamine (7460) II
Phencyclidine (7471) II
1-Piperidinocyclohexanecarbonitrile (8603) II
Alphaprodine (9010) II
Cocaine (9041) II
Codeine (9050) II
Dihydrocodeine (9120) II
Oxycodone (9143) II
Hydromorphone (9150) II
Diphenoxylate (9170) II
Benzoylecgonine (9180) II
Ethylmorphine (9190) II
Hydrocodone (9193) II
Levomethorphan (9210) II
Levorphanol (9220) II
Isomethadone (9226) II
Meperidine (9230) II
Methadone (9250) II
Methadone-intermediate (9254) II
Morphine (9300) II
Thebaine (9333) II
Levo-alphacetylmethadol (9648) II
Oxymorphone (9652) II
Noroxymorphone (9668) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to manufacture small quantities of the listed controlled substances to make deuterated and non-deuterated drug reference standards which will be distributed to analytical and forensic laboratories for drug testing programs.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration. 

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than April 16, 2001.

Dated: January 25, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.

[FR Doc. 01-3752 Filed 2-13-01; 8:45 am]

BILLING CODE 4410-09-M

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility